Fortress Biotech (FBIO) Net Margin (2015 - 2026)
Fortress Biotech's Net Margin was -13.23% in Q2 2026, down 94.60 percentage points from 81.37% a year earlier.
Powered by 
Analysis
Fortress Biotech (FBIO) Net Margin (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Fortress Biotech's Net Margin was 12.14% through Jun 30, 2026, up 52.70 percentage points year-over-year; for FY2025, it came in at -2.97%, up 93.93 percentage points from FY2024.
- Net Margin shows a five-year change of +99.06 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -96.91% in FY2024 (-15.65 pp), -81.25% in FY2023 (+43.65 pp), -124.91% in FY2022 (-30.85 pp) and -94.06% in FY2021 (+7.98 pp).
- Quarterly Net Margin has moved between -189.44% (Q1 2023) and 81.37% (Q2 2025) over five years.
- Compared with a year earlier, Net Margin was higher in four of the last seven quarters, with an average year-over-year change of +25.11 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q2 2025 (a gain of 170.92 percentage points); the worst was Q4 2021 (a drop of 134.20 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Fortress Biotech | 62.47 Mn | -555.55 Mn | 12.58 Mn | -13.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.23% |
| Dec 31, 2025 | -38.55% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 81.37% |
| Mar 31, 2025 | -96.77% |
| Dec 31, 2024 | -63.84% |
| Sep 30, 2024 | -102.81% |
| Jun 30, 2024 | -89.55% |
| Mar 31, 2024 | -137.06% |
| Dec 31, 2023 | -56.59% |
| Sep 30, 2023 | -20.30% |
| Jun 30, 2023 | -154.82% |
| Mar 31, 2023 | -189.44% |
| Dec 31, 2022 | -176.22% |
| Sep 30, 2022 | -148.35% |
| Jun 30, 2022 | -128.13% |
| Mar 31, 2022 | -65.87% |
| Dec 31, 2021 | -172.71% |
| Sep 30, 2021 | -98.56% |
| Jun 30, 2021 | -19.81% |
API Access
Fortress Biotech Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "FBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=FBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();